tiotropium bromide

(redirected from Tiotropium)
Also found in: Medical, Wikipedia.
Translations

tiotropium bromide

n bromuro de tiotropio
References in periodicals archive ?
Contract notice: Conclusion of non-exclusive discount agreements pursuant to section 130a (8) sgb v on medicines containing the active substance olodaterol + tiotropium bromide (atc code: R03al06) within the framework of a so-called open-house model
German pharmaceutical company Boehringer Ingelheim reported on Thursday the receipt of approval from the US Food and Drug Administration (FDA) for new labeling for Stiolto Respimat (tiotropium bromide & olodaterol) Inhalation Spray for reduction in COPD exacerbations, including chronic bronchitis and emphysema.
Researchers presented new data from a randomized, double-blinded study comparing the efficacy of YUPELRI to tiotropium in patients with moderate to very severe COPD and suboptimal peak inspiratory flow rates (less than 60 L/min).
Adolescent or school-aged children with severe persistent asthma (step 4) should take a medium or high dose of ICS together with LABA, with the authors recommending adding tiotropium to a soft-mist inhaler, combination high-dose ICS and LTRA, or a combination high-dose ICS and theophylline.
Tiotropium is a once-daily, long-acting muscarinic antagonist (LAMA) that has established effectiveness in chronic obstructive pulmonary disease (COPD), improving lung function, quality of life, and exacerbation frequency [8-10].
Objective: To investigate the clinical efficacy of tiotropium in children with asthma.
Black adults with asthma did not see significant differences in time to exacerbation after adding a long-acting beta-agonist to their inhaled corticosteroid treatment, compared with adding tiotropium, according to results from a randomized, open-label trial.
Boehringer Ingelheim announced that the Food and Drug Administration approved once-daily Stiolto Respimat (tiotropium bromide and olodaterol) inhalation spray as a long-term, once-a-day maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
[9] Although there are conflicting data regarding the efficacy of combination of tiotropium and salmeterol [10-12] but the addition of formoterol with tiotropium also have not shown consistent outcomes.
The lost prescription drugs consist of: Amlodipin, Atenolol, Atorvastatin, Clopidogrel, Cocodamol, Duloxetine, Gyceryl Trinitrate spray, Lansoprazole, Omacor, Perindopril, Erbumine, Pregabalin, Tiotropium inhaler, Tramadol, Ventolin and Zopiclone.
Boehringer Ingelheim's New Drug Application (NDA) has been accepted by the FDA for the fixed-dose combination (FDC) of tiotropium and olodaterol delivered via the Respimat inhaler for the proposed indication of long-term, once-daily maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Trials on nearly 1,000 people with uncontrolled asthma showed the drug tiotropium taken through a mist inhaler opened constricted airways and appeared to improve lung function, the Daily Mail reported.